KODAK ltEK BUYS STAKE ENZON ltENZN Eastman Kodak acquired 187 pct equity interest Enzon Inc pharmaceutical company specializing protein therapy Kodak secured worldwide marketing rights Enzons PEG enzymes treatment oxygen toxicity disorders hyperuricemia gout company acquired mln Enzon shares 15 mln dlrs loans Enzon mln dlrs interest 30000 dlrs credited purchase price Kodak drugs covered marketing rights initial stages US Food Drug Administration approval process investment provide capital complete FDA review process provide marketing outlet drugs drugs PEGsuperoxide disdmutase PEGcatalase oxygen toxicity disorders oftenfatal tissue damage severe burns organ transplants heart attacks trauma PEGuricase treatment gout conditions caused buildup high levels uric acid body